Inhibiting β-Catenin by β-Carboline-Type MDM2 Inhibitor for Pancreatic Cancer Therapy
The β-catenin and MDM2 oncoproteins are overexpressed and constitutively activated in human pancreatic cancer and contribute to its initiation, progression, and metastasis. The Wnt/β-catenin signaling pathway strongly interacts with the MDM2-p53 signaling pathway, accelerating the tumorigenesis and...
Saved in:
Main Authors: | Jiang-Jiang Qin (Author), Wei Wang (Author), Xin Li (Author), Hemantkumar Deokar (Author), John K. Buolamwini (Author), Ruiwen Zhang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2018-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeting the NFAT1-MDM2-MDMX Network Inhibits the Proliferation and Invasion of Prostate Cancer Cells, Independent of p53 and Androgen
by: Jiang-Jiang Qin, et al.
Published: (2017) -
Synthesis and biological evaluation of novel N9-heterobivalent β-carbolines as angiogenesis inhibitors
by: Liang Guo, et al.
Published: (2019) -
Irigenin inhibits glioblastoma progression through suppressing YAP/β-catenin signaling
by: Jiayun Xu, et al.
Published: (2022) -
Monoamine Oxidase Inhibition by Plant-Derived β-Carbolines; Implications for the Psychopharmacology of Tobacco and Ayahuasca
by: Ilana Berlowitz, et al.
Published: (2022) -
MDM2 inhibitor ameliorates cisplatin‐induced nephropathy via NFκΒ signal inhibition
by: Tomoyuki Fujikura, et al.
Published: (2019)